ZIACCHI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 7.760
EU - Europa 7.052
AS - Asia 6.747
AF - Africa 496
SA - Sud America 423
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.493
Nazione #
US - Stati Uniti d'America 7.682
SG - Singapore 2.232
CN - Cina 1.874
IT - Italia 1.754
GB - Regno Unito 1.585
VN - Vietnam 1.234
DE - Germania 961
SE - Svezia 582
HK - Hong Kong 565
UA - Ucraina 533
IN - India 378
RU - Federazione Russa 374
FR - Francia 306
BR - Brasile 292
IE - Irlanda 235
CI - Costa d'Avorio 203
NL - Olanda 198
KR - Corea 144
EE - Estonia 133
FI - Finlandia 126
JP - Giappone 118
ZA - Sudafrica 106
TG - Togo 75
AR - Argentina 71
BG - Bulgaria 65
JO - Giordania 61
SC - Seychelles 57
CH - Svizzera 47
CA - Canada 40
ID - Indonesia 36
BE - Belgio 27
IR - Iran 27
MX - Messico 27
AT - Austria 26
BD - Bangladesh 24
NG - Nigeria 24
PL - Polonia 23
EC - Ecuador 18
RO - Romania 15
AU - Australia 12
CL - Cile 11
CO - Colombia 11
GR - Grecia 11
EG - Egitto 10
ES - Italia 10
IQ - Iraq 10
PY - Paraguay 8
LT - Lituania 7
TR - Turchia 7
TH - Thailandia 6
UY - Uruguay 6
PK - Pakistan 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
LB - Libano 4
LU - Lussemburgo 4
MA - Marocco 4
MY - Malesia 4
UZ - Uzbekistan 4
HN - Honduras 3
KE - Kenya 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
SA - Arabia Saudita 3
SN - Senegal 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
VA - Santa Sede (Città del Vaticano) 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SI - Slovenia 1
SV - El Salvador 1
Totale 22.491
Città #
Singapore 1.497
Southend 1.367
Ashburn 962
Fairfield 683
Hong Kong 564
Chandler 526
Santa Clara 456
Jacksonville 387
Wilmington 354
Hefei 345
Princeton 343
Dong Ket 335
Seattle 329
Woodbridge 329
Houston 306
Beijing 290
Cambridge 237
Dublin 235
Ann Arbor 222
Boardman 216
Abidjan 203
Westminster 148
Milan 143
Padova 141
Los Angeles 133
Seoul 133
Nanjing 130
Ho Chi Minh City 116
Tokyo 115
Berlin 108
Rome 106
Bologna 104
New York 100
Helsinki 93
Jinan 84
Hanoi 78
Saint Petersburg 78
Shenyang 78
Buffalo 76
Medford 76
Bremen 75
Lomé 75
Dallas 70
Turin 70
Changsha 67
Munich 67
Sofia 64
Amman 61
Mülheim 60
Mahé 51
Nanchang 48
San Diego 46
Frankfurt am Main 44
Redondo Beach 44
Hebei 41
São Paulo 39
Guangzhou 37
Bari 34
Des Moines 34
Tianjin 34
Bengaluru 33
Zhengzhou 33
Naples 30
Bern 29
Olalla 28
Brussels 27
Jiaxing 27
Verona 27
Yubileyny 27
Chicago 26
Falkenstein 26
Abeokuta 24
Ningbo 22
Shanghai 22
Hangzhou 21
Turku 21
Taizhou 20
Dearborn 19
Haikou 19
Jakarta 19
Warsaw 19
Brooklyn 18
Düsseldorf 18
London 18
Lanzhou 17
Nuremberg 17
Mountain View 16
Phoenix 16
Buenos Aires 15
Bühl 15
Toronto 15
Florence 14
Hyderabad 14
Palermo 14
Pune 14
Rio de Janeiro 14
Boydton 13
Chengdu 13
Haiphong 13
Johannesburg 13
Totale 14.093
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.033
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 255
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 222
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 209
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 198
AF burden is important - Fact or fiction? 196
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 193
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 185
Electrocardiographic remodeling during cardiac resynchronization therapy 183
Automatic verification of ventricular stimulation: fusion management algorithm 177
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 176
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 174
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 174
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 166
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 165
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 165
Automatic management of left ventricular stimulation: hints for technologic improvement. 163
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 163
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 162
Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only? 161
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 161
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 159
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 158
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 156
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 155
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 155
The empowerment of translational research: lessons from laminopathies. 154
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 154
Wireless Endocardial Atrial (and Ventricular) Sensing with no Implanted Power Source: a Proposal 154
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 153
Implantation of cardioverter-defibrillator: Effects on shoulder function. 152
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 152
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 151
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 151
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 150
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 150
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 149
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 148
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 147
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 146
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 146
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 145
Atrial fibrillation and heart failure: does one epidemic feed he other? 145
Confronto fra impedenziometria transtoracica ed ecocardiografia doppler nell'ottimizzazione della programmazione dell'intervallo ventricolo-ventricolare. 144
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 143
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 142
Is ventricular sensing always right, when it is left? 141
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 141
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 140
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 138
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 138
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 137
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 137
Predictors of long-term survival free from relapses after extraction of infected CIED. 137
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 137
Phrenic stimulation: a challenge for cardiac resynchronization therapy 136
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 135
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 134
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 133
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 133
Role of drugs and devices in patients at risk of sudden cardiac death. 133
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 132
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 131
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy 129
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 129
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 128
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 128
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 128
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 128
Automatic verification of ventricular stimulation: fusion management algorithm 128
Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. 127
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 127
Cardioversione elettrica di fibrillazione e flutter atriale: risultati a distanza. 125
Is cardiac resynchronization therapy cost-effective? 125
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 124
Risultati a lungo termine della cardioversione elettrica di fibrillazione o flutter atriale. 124
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 124
Cardiac resynchronisation therapy: effect on intra-ventricular and inter-ventricular dyssynchrony at radionuclide angiography by Fourier phase analysis 123
Risultati e complicanze dell'impianto di cardioverter-defibrillatore in pazienti con cardiomiopatia aritmogena del ventricolo destro. 122
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 122
Il follow up di pace maker e defibrillatori: Valutazione degli attuali disagi per i pazienti e del potenziale impatto di sistemi di controllo remoto mediante telemedicina. Abstract 69° Congresso Nazionale Società Italiana di Cardiologia 122
Cardioversione elettrica associata ad impianto di dispositivo per resincronizzazione cardiaca: quali risultati a distanza? 121
Long-term follow-up of patients with syncope evaluated by head-up tilt test. 121
Cardiac resynchronization therapy: update on clinical studies 121
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 120
Follow-up a lungo termine di pazienti con sincope valutati con tilt test 120
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. 119
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 118
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 118
The challenge of preventing stroke in elderly patients with atrial fibrillation. 118
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. 117
Ventricular dyssynchrony at rest and during exercise assessed by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 117
Cardiac resynchronization therapy in heart failure. Doubts and certainties. 117
Il rimodellamento elettrico e strutturale nella terapia di resincronizzazione cardiaca. 116
Interventricular delay optimization: a comparison among three different echocardiographic methods. 116
Effetti della terapia di resincronizzazione cardiaca sulla funzione diastolica: valutazione con angiocardioscintigrafia con radionucleotide. 115
Hybrid transcatheter left ventricular reconstruction for the treatment of ischemic cardiomyopathy 114
The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet? 114
Ottimizzazione ecocardiografica del ritardo atrioventricolare nella resincronizzazione cardiaca: variazioni a lungo termine. 113
Prolactin Inhibition to Treat Postpartum Arrhythmic Storm 112
Totale 15.243
Categoria #
all - tutte 61.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.569 0 0 0 0 0 0 33 119 175 126 89 1.027
2021/20222.658 219 142 151 233 239 169 44 244 73 135 515 494
2022/20233.197 292 369 146 411 182 189 103 154 634 190 262 265
2023/20241.110 80 162 84 70 109 233 76 86 52 60 48 50
2024/20254.108 199 698 314 304 733 194 165 120 53 276 217 835
2025/20264.332 697 691 854 644 954 488 4 0 0 0 0 0
Totale 22.885